Angel News

Back to Homepage

1st July 2020

Beckley Psytech raises £3m to develop ground-breaking psychedelic medicines

Beckley Psytech, the psychedelic medicine company, has raised £3m of Series A funding to develop a pipeline of psychedelic drugs into licensed pharmaceutical medicines for treating psychiatric and neurological diseases. Investors in the round include prominent British businessmen Jim Mellon and Richard Reed, co-founder of Innocent Drinks.

The Beckley Psytech team comprises talent from the psychedelic and pharmaceutical fields. It was co-founded by world-renowned leader in psychedelic research Lady Amanda Feilding and CEO Cosmo Feilding Mellen.

...

Register / Login now to read full story

In order to read the full story we need you to be registered with us, please click the links below to login or register.

Login / Register

Add a comment:

Name:

Email:

Comment:

Enter the characters in the image shown:



Back to Homepage